Conroe has enforced a moratorium in its northern portion, halting new development due to a lack of available water capacity.

Short interest in Cencora Inc (NYSE:COR) decreased during the last reporting period, falling from 6.73M to 6.63M. This put 5.89% of the company's publicly available shares short. Short interest in ...

Shares of Cencora (COR) have been strong performers lately, with the stock up 11.2% over the past month. The stock hit a new 52-week high of $309.35 in the previous session. Cencora has gained 35. ...

Full Year Revenue Growth Guidance: 8% to 10%. Full Year Operating Income Growth Guidance: 13.5% to 15.5%. Cencora Inc (NYSE:COR) reported strong revenue growth of 10% and adjusted diluted EPS growth ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and ...

Hello, everyone, and thank you for joining the Cencora Fiscal 2025 Second Quarter Results Conference Call. My name is Lucy, and I will be coordinating your call today. [Operator Instructions] I ...

Cencora delivered a strong quarter with notable growth in the U.S. Healthcare Solutions segment, driven by specialty products and strategic investments. The company raised its full-year EPS ...

We recently published a list of Jim Cramer Rediscovers Love For Magnificent 7 & Discusses These 11 Stocks In this article, we are going to take a look at where Cencora, Inc. (NYSE:COR) stands ...

May 7 (Reuters) - U.S. drug distributor Cencora (COR.N), opens new tab raised its annual profit forecast on Wednesday, driven by robust demand for costly specialty medicines and weight-loss drugs.

CONSHOHOCKEN, Pa. (AP) — CONSHOHOCKEN, Pa. (AP) — Cencora, Inc. (COR) on Wednesday reported fiscal second-quarter profit of $717.9 million. On a per-share basis, the Conshohocken, Pennsylvania ...